Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Syed H. Haider, Assad Oskuei, George Crowley, Sophia Kwon, Rachel Lam, Jessica Riggs, Mena Mikhail, Angela Talusan, Arul Veerappan, James S. Kim, Erin J. Caraher, Anna Nolan. Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review. Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018

Member's Comments

No comment yet.

Related content which might interest you: Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Measures of lung function and their relationship with advanced glycation end-products Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019 Year: 2020 Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Plasma advanced glycation end-products and skin autofluorescence are increased in COPD Source: Eur Respir J 2014; 43: 430-438 Year: 2013 Advanced glycation endproducts and lung function in COPD Source: International Congress 2014 – Best posters in chronic care Year: 2014 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Importance of the receptor for advanced glycation end products in the respiratory mechanics Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Increased expression of receptor for advanced glycation end products in COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Soluble RAGE is deficient in neutrophilic asthma and COPD Source: Eur Respir J 2012; 39: 721-729 Year: 2012 Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013